A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0)
29 augusti 2012 uppdaterad av: AstraZeneca
A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 (Zibotentan) 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients
Enthuse M0 is a large phase III clinical trial studying the efficacy of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC).
This clinical trial will test if the Endothelin A Receptor Antagonist ZD4054 (Zibotentan) can improve progression-free survival and overall survival against a background of existing prostate cancer treatments.
ZD4054 (Zibotentan) is a new type of agent, which is thought to slow tumour growth and spread by blocking Endothelin receptor activity. This trial will look at the effects of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC) patients who have had rising PSA after surgical or medical castration but have no evidence of metastases.
All patients participating in this clinical trial will receive existing prostate cancer treatments in addition to trial therapy.
Half the patients will receive ZD4054 (Zibotentan) , and half the patients will receive placebo in addition to standard prostate cancer therapy. By participating in this trial there is a 50% chance that patients will receive an agent that may slow the progression of the tumour.
No patients will be deprived of standard prostate cancer therapy.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
2577
Fas
- Fas 3
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Santa Fe, Argentina
- Research Site
-
-
Buenos Aires
-
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Research Site
-
-
Santa Fe
-
Rosario, Santa Fe, Argentina
- Research Site
-
-
-
-
-
Sydney, Australien
- Research Site
-
-
New South Wales
-
Darlinghurst, New South Wales, Australien
- Research Site
-
Hornsby, New South Wales, Australien
- Research Site
-
Westmead, New South Wales, Australien
- Research Site
-
Wollongong, New South Wales, Australien
- Research Site
-
-
Victoria
-
Wodonga, Victoria, Australien
- Research Site
-
-
Western Australia
-
Nedlands, Western Australia, Australien
- Research Site
-
-
-
-
-
(Wilrijk) Antwerpen, Belgien
- Research Site
-
Brussels, Belgien
- Research Site
-
Edegem, Belgien
- Research Site
-
Gent, Belgien
- Research Site
-
Kortrijk, Belgien
- Research Site
-
Leuven, Belgien
- Research Site
-
Liege, Belgien
- Research Site
-
-
-
-
-
Sao Paulo, Brasilien
- Research Site
-
-
Goias
-
Goiania, Goias, Brasilien
- Research Site
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasilien
- Research Site
-
-
PR
-
Londrina, PR, Brasilien
- Research Site
-
-
Parana
-
Curitiba, Parana, Brasilien
- Research Site
-
-
RJ
-
Rio de Janeiro, RJ, Brasilien
- Research Site
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien
- Research Site
-
-
Sao Paulo
-
Santo Andre, Sao Paulo, Brasilien
- Research Site
-
-
-
-
-
La Serena, Chile
- Research Site
-
Santiago, Chile
- Research Site
-
Temuco, Chile
- Research Site
-
Vina del Mar, Chile
- Research Site
-
-
-
-
-
Bogota, Colombia
- Research Site
-
Medellin, Colombia
- Research Site
-
-
-
-
-
Aalborg, Danmark
- Research Site
-
Frederiksberg, Danmark
- Research Site
-
Herlev, Danmark
- Research Site
-
Holstebro, Danmark
- Research Site
-
Kobenhavn, Danmark
- Research Site
-
Odense, Danmark
- Research Site
-
Roskilde, Danmark
- Research Site
-
-
-
-
-
Helsinki, Finland
- Research Site
-
Joensuu, Finland
- Research Site
-
Oulu, Finland
- Research Site
-
Seinajoki, Finland
- Research Site
-
Tampere, Finland
- Research Site
-
-
-
-
-
Caen cedex, Frankrike
- Research Site
-
Creteil, Frankrike
- Research Site
-
Lille, Frankrike
- Research Site
-
Lyon, Frankrike
- Research Site
-
Lyon cedex 03, Frankrike
- Research Site
-
Marseille, Frankrike
- Research Site
-
Montpellier, Frankrike
- Research Site
-
Orleans Cedex, Frankrike
- Research Site
-
Paris, Frankrike
- Research Site
-
Pierre Benite cedex, Frankrike
- Research Site
-
Poitiers Cedex, Frankrike
- Research Site
-
Reims, Frankrike
- Research Site
-
Reims cedex, Frankrike
- Research Site
-
Rennes cedex 9, Frankrike
- Research Site
-
Rouen, Frankrike
- Research Site
-
Suresnes, Frankrike
- Research Site
-
Toulouse, Frankrike
- Research Site
-
Vandoeuvre-les-Nancy cedex, Frankrike
- Research Site
-
Villejuif, Frankrike
- Research Site
-
-
-
-
Arizona
-
Tucson, Arizona, Förenta staterna
- Research Site
-
-
California
-
Greenbrae, California, Förenta staterna
- Research Site
-
Los Angeles, California, Förenta staterna
- Research Site
-
San Diego, California, Förenta staterna
- Research Site
-
San Francisco, California, Förenta staterna
- Research Site
-
-
Colorado
-
Denver, Colorado, Förenta staterna
- Research Site
-
-
Connecticut
-
Norwich, Connecticut, Förenta staterna
- Research Site
-
-
District of Columbia
-
Washington, District of Columbia, Förenta staterna
- Research Site
-
-
Florida
-
Boca Raton, Florida, Förenta staterna
- Research Site
-
Miami, Florida, Förenta staterna
- Research Site
-
Ocala, Florida, Förenta staterna
- Research Site
-
Port St. Lucie, Florida, Förenta staterna
- Research Site
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna
- Research Site
-
Macon, Georgia, Förenta staterna
- Research Site
-
-
Kansas
-
Kansas City, Kansas, Förenta staterna
- Research Site
-
-
Louisiana
-
New Orleans, Louisiana, Förenta staterna
- Research Site
-
-
Maryland
-
Baltimore, Maryland, Förenta staterna
- Research Site
-
Rockville, Maryland, Förenta staterna
- Research Site
-
-
Minnesota
-
Minneapolis, Minnesota, Förenta staterna
- Research Site
-
-
Nebraska
-
Lincoln, Nebraska, Förenta staterna
- Research Site
-
-
Nevada
-
Las Vegas, Nevada, Förenta staterna
- Research Site
-
-
New York
-
Brooklyn, New York, Förenta staterna
- Research Site
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna
- Research Site
-
-
North Dakota
-
Bismarck, North Dakota, Förenta staterna
- Research Site
-
-
Ohio
-
Canton, Ohio, Förenta staterna
- Research Site
-
Cincinnati, Ohio, Förenta staterna
- Research Site
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna
- Research Site
-
Pittsburgh, Pennsylvania, Förenta staterna
- Research Site
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna
- Research Site
-
Mystle Beach, South Carolina, Förenta staterna
- Research Site
-
Raleigh, South Carolina, Förenta staterna
- Research Site
-
-
Tennessee
-
Memphis, Tennessee, Förenta staterna
- Research Site
-
Nashville, Tennessee, Förenta staterna
- Research Site
-
-
Texas
-
San Antonio, Texas, Förenta staterna
- Research Site
-
-
Vermont
-
Burlington, Vermont, Förenta staterna
- Research Site
-
-
Washington
-
Seattle, Washington, Förenta staterna
- Research Site
-
Wenatchee, Washington, Förenta staterna
- Research Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Förenta staterna
- Research Site
-
-
-
-
-
New Delhi, Indien
- Research Site
-
-
Gujarat
-
Ahmedabad, Gujarat, Indien
- Research Site
-
Nadiad, Gujarat, Indien
- Research Site
-
-
Kerala
-
Kochi, Kerala, Indien
- Research Site
-
-
Maharashtra
-
Pune, Maharashtra, Indien
- Research Site
-
-
Tamil Nadu, India
-
Chennai, Tamil Nadu, India, Indien
- Research Site
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, Indien
- Research Site
-
-
West Bengal
-
Kolkota, West Bengal, Indien
- Research Site
-
-
-
-
-
Dublin, Irland
- Research Site
-
Dublin 7, Irland
- Research Site
-
Dublin 8, Irland
- Research Site
-
-
-
-
-
Be'er Sheva, Israel
- Research Site
-
Be'er-Ya'akov, Israel
- Research Site
-
Haifa, Israel
- Research Site
-
Holon, Israel
- Research Site
-
Jeruslaem, Israel
- Research Site
-
Petah-Tikva, Israel
- Research Site
-
Tel-HaShomer - Ramat Gan, Israel
- Research Site
-
-
-
-
-
Ancona, Italien
- Research Site
-
Bari, Italien
- Research Site
-
Bergamo, Italien
- Research Site
-
Bologna, Italien
- Research Site
-
Catania, Italien
- Research Site
-
Como, Italien
- Research Site
-
Firenze, Italien
- Research Site
-
Genova, Italien
- Research Site
-
Messina, Italien
- Research Site
-
Milano, Italien
- Research Site
-
Pisa, Italien
- Research Site
-
Rome, Italien
- Research Site
-
Terni, Italien
- Research Site
-
Varese, Italien
- Research Site
-
-
-
-
-
Kyoto, Japan
- Research Site
-
Nagasaki, Japan
- Research Site
-
-
Aomori
-
Hirosaki-City, Aomori, Japan
- Research Site
-
-
Chiba
-
Chiba-City, Chiba, Japan
- Research Site
-
Narashino-city, Chiba, Japan
- Research Site
-
-
Ehime
-
Matsuyama-City, Ehime, Japan
- Research Site
-
-
Fukuoka
-
Fukuoka-City, Fukuoka, Japan
- Research Site
-
-
Gunma
-
Maebashi-City, Gunma, Japan
- Research Site
-
-
Hiroshima
-
Otake-City, Hiroshima, Japan
- Research Site
-
-
Hokkaido
-
Sapporo-City, Hokkaido, Japan
- Research Site
-
-
Hyogo
-
Kobe-City, Hyogo, Japan
- Research Site
-
-
Ibaraki
-
Ibaraki-machi, Ibaraki, Japan
- Research Site
-
Mito-City, Ibaraki, Japan
- Research Site
-
Tsukuba-City, Ibaraki, Japan
- Research Site
-
-
Kagawa
-
Kita-gun, Kagawa, Japan
- Research Site
-
-
Kanagawa
-
Sagamihara-City, Kanagawa, Japan
- Research Site
-
-
Kyoto
-
Kamigyo-ku, Kyoto, Japan
- Research Site
-
Kyoto-City, Kyoto, Japan
- Research Site
-
-
Miyagi
-
Sendai-City, Miyagi, Japan
- Research Site
-
-
Nagano
-
Ueda-City, Nagano, Japan
- Research Site
-
-
Nara
-
Kashihara, Nara, Japan
- Research Site
-
-
Oita
-
Oita-City, Oita, Japan
- Research Site
-
-
Okayama
-
Kurashiki, Okayama, Japan
- Research Site
-
-
Osaka
-
Osaka-City, Osaka, Japan
- Research Site
-
Osaka-Sayama-City, Osaka, Japan
- Research Site
-
Suita-City, Osaka, Japan
- Research Site
-
-
Saitama
-
Wako-City, Saitama, Japan
- Research Site
-
-
Shizuoka
-
Hamamatsu-city, Shizuoka, Japan
- Research Site
-
Sunto-gun, Shizuoka, Japan
- Research Site
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan
- Research Site
-
Fuchu_city, Tokyo, Japan
- Research Site
-
Itabashi-Ku, Tokyo, Japan
- Research Site
-
Meguro-ku, Tokyo, Japan
- Research Site
-
Minato-Ku, Tokyo, Japan
- Research Site
-
Mitaka-City, Tokyo, Japan
- Research Site
-
Shinjuku-ku, Tokyo, Japan
- Research Site
-
-
-
-
-
Ankara, Kalkon
- Research Site
-
Istanbul, Kalkon
- Research Site
-
Izmir, Kalkon
- Research Site
-
-
-
-
Alberta
-
Calgary, Alberta, Kanada
- Research Site
-
Edmonton, Alberta, Kanada
- Research Site
-
-
British Columbia
-
Vancouver, British Columbia, Kanada
- Research Site
-
Victoria, British Columbia, Kanada
- Research Site
-
-
Manitoba
-
Winnipeg, Manitoba, Kanada
- Research Site
-
-
Ontario
-
Burlington, Ontario, Kanada
- Research Site
-
Hamilton, Ontario, Kanada
- Research Site
-
Kingston, Ontario, Kanada
- Research Site
-
Kitchener, Ontario, Kanada
- Research Site
-
London, Ontario, Kanada
- Research Site
-
North York, Ontario, Kanada
- Research Site
-
Oakville, Ontario, Kanada
- Research Site
-
Toronto, Ontario, Kanada
- Research Site
-
-
Quebec
-
Greenfeild Park, Quebec, Kanada
- Research Site
-
Montreal, Quebec, Kanada
- Research Site
-
Point-Claire, Quebec, Kanada
- Research Site
-
Quebec City, Quebec, Kanada
- Research Site
-
Sherbrooke, Quebec, Kanada
- Research Site
-
-
-
-
-
Beijing, Kina
- Research Site
-
Chongqing, Kina
- Research Site
-
Guangzhou City, Kina
- Research Site
-
Hubei, Kina
- Research Site
-
Jiangsu, Kina
- Research Site
-
Shanghai, Kina
- Research Site
-
Shanxi, Kina
- Research Site
-
Tianjin, Kina
- Research Site
-
Zejiang, Kina
- Research Site
-
-
Jiangsu
-
Nanjing, Jiangsu, Kina
- Research Site
-
-
Zhejiang
-
Hangzhou, Zhejiang, Kina
- Research Site
-
-
-
-
Gyeonggi-do
-
Bundang-Gu, Seongnam-si, Gyeonggi-do, Korea, Republiken av
- Research Site
-
-
Pusan
-
Seo-gu, Pusan, Korea, Republiken av
- Research Site
-
-
Seoul
-
Gangnam-gu, Seoul, Korea, Republiken av
- Research Site
-
Seodaemun-gu, Seoul, Korea, Republiken av
- Research Site
-
Seongbuk-gu, Seoul, Korea, Republiken av
- Research Site
-
Songpa-gu, Seoul, Korea, Republiken av
- Research Site
-
-
-
-
-
Liepaja, Lettland
- Research Site
-
Riga, Lettland
- Research Site
-
-
-
-
Ciudad de Mexico
-
Distrito Federal, Ciudad de Mexico, Mexiko
- Research Site
-
-
Distrito Federal
-
Mexico DF, Distrito Federal, Mexiko
- Research Site
-
-
-
-
-
Amsterdam, Nederländerna
- Research Site
-
Arnhem, Nederländerna
- Research Site
-
Eindhoven, Nederländerna
- Research Site
-
Hertogenbosch, Nederländerna
- Research Site
-
Nijmegen, Nederländerna
- Research Site
-
Rotterdam, Nederländerna
- Research Site
-
Tilburg, Nederländerna
- Research Site
-
-
-
-
-
Tonsberg, Norge
- Research Site
-
Trondheim, Norge
- Research Site
-
-
-
-
-
Arequipa, Peru
- Research Site
-
Bellavista, Peru
- Research Site
-
Jesus Maria, Peru
- Research Site
-
Lima, Peru
- Research Site
-
-
-
-
-
Gdynia, Polen
- Research Site
-
Kielce, Polen
- Research Site
-
Koscierzyna, Polen
- Research Site
-
Szczecin, Polen
- Research Site
-
Warszawa, Polen
- Research Site
-
Wroclaw, Polen
- Research Site
-
-
-
-
-
Coimbra, Portugal
- Research Site
-
Porto, Portugal
- Research Site
-
-
-
-
-
Bucuresti, Rumänien
- Research Site
-
Cluj-Napoca, Rumänien
- Research Site
-
-
Timis
-
Timisoara, Timis, Rumänien
- Research Site
-
-
-
-
-
Barnaul, Ryska Federationen
- Research Site
-
Kursk, Ryska Federationen
- Research Site
-
Moscow, Ryska Federationen
- Research Site
-
Sochi, Ryska Federationen
- Research Site
-
St.Petersburg, Ryska Federationen
- Research Site
-
Voronezh, Ryska Federationen
- Research Site
-
-
Omsk region
-
Omsk, Omsk region, Ryska Federationen
- Research Site
-
-
Russia
-
Izhevsk, Russia, Ryska Federationen
- Research Site
-
-
Tomsk Region
-
Tomsk, Tomsk Region, Ryska Federationen
- Research Site
-
-
-
-
-
Aarau, Schweiz
- Research Site
-
CH-4031 Basel, Schweiz
- Research Site
-
Locarno, Schweiz
- Research Site
-
Zuerich, Schweiz
- Research Site
-
-
-
-
-
Belgrade, Serbien
- Research Site
-
Nis, Serbien
- Research Site
-
Novi Sad, Serbien
- Research Site
-
-
-
-
-
A Corunna, Spanien
- Research Site
-
Barcelona, Spanien
- Research Site
-
Madrid, Spanien
- Research Site
-
Sevilla, Spanien
- Research Site
-
Valencia, Spanien
- Research Site
-
-
Alicante
-
Elche, Alicante, Spanien
- Research Site
-
-
Bizkaia
-
Barakaldo, Bizkaia, Spanien
- Research Site
-
-
Vizcaya
-
Bilbao, Vizcaya, Spanien
- Research Site
-
-
-
-
-
Cambridge, Storbritannien
- Research Site
-
Coventry, Storbritannien
- Research Site
-
Glasgow, Storbritannien
- Research Site
-
Huddersfield, Storbritannien
- Research Site
-
Liverpool, Storbritannien
- Research Site
-
London, Storbritannien
- Research Site
-
Manchester, Storbritannien
- Research Site
-
Newcastle upon Tyne, Storbritannien
- Research Site
-
-
Berkshire
-
Reading, Berkshire, Storbritannien
- Research Site
-
-
East Yorkshire
-
Cottingham, East Yorkshire, Storbritannien
- Research Site
-
-
Hertfordshire
-
Stevenage, Hertfordshire, Storbritannien
- Research Site
-
-
Kent
-
Maidstone, Kent, Storbritannien
- Research Site
-
-
Surrey
-
Guildford, Surrey, Storbritannien
- Research Site
-
-
-
-
-
Gothenburg, Sverige
- Research Site
-
Helsingborg, Sverige
- Research Site
-
Jonkoping, Sverige
- Research Site
-
Orebro, Sverige
- Research Site
-
Stockholm, Sverige
- Research Site
-
Uppsala, Sverige
- Research Site
-
-
-
-
-
Pietermaritzburg, Sydafrika
- Research Site
-
Pretoria, Sydafrika
- Research Site
-
-
Cape Town
-
Observatory, Cape Town, Sydafrika
- Research Site
-
Tygerberg, Cape Town, Sydafrika
- Research Site
-
-
Durban
-
Overport, Durban, Sydafrika
- Research Site
-
-
Johannesburg
-
Parktown, Johannesburg, Sydafrika
- Research Site
-
-
-
-
-
Taipei, Taiwan
- Research Site
-
-
-
-
-
Brno, Tjeckien
- Research Site
-
Hradec Kralove, Tjeckien
- Research Site
-
Jablonec nad Nisou, Tjeckien
- Research Site
-
Kromeriz, Tjeckien
- Research Site
-
Olomouc, Tjeckien
- Research Site
-
Prague 2, Tjeckien
- Research Site
-
Prague 4, Tjeckien
- Research Site
-
Prague 6, Tjeckien
- Research Site
-
Praha, Tjeckien
- Research Site
-
Usti nad Labem, Tjeckien
- Research Site
-
-
-
-
-
Augsburg, Tyskland
- Research Site
-
Bad Ems, Tyskland
- Research Site
-
Berlin, Tyskland
- Research Site
-
Bonn, Tyskland
- Research Site
-
Borken, Tyskland
- Research Site
-
Chemnitz, Tyskland
- Research Site
-
Emmendingen, Tyskland
- Research Site
-
Fuerth, Tyskland
- Research Site
-
Gelsenkirchen-Buer, Tyskland
- Research Site
-
Germering, Tyskland
- Research Site
-
Goettingen, Tyskland
- Research Site
-
Holzminden, Tyskland
- Research Site
-
Kirchheim/Teck, Tyskland
- Research Site
-
Leipzig, Tyskland
- Research Site
-
Lubeck, Tyskland
- Research Site
-
Mannheim, Tyskland
- Research Site
-
Muehlacker, Tyskland
- Research Site
-
Muehlheim an der Ruhr, Tyskland
- Research Site
-
Muenchen, Tyskland
- Research Site
-
Muenchen-Planegg, Tyskland
- Research Site
-
Muenster, Tyskland
- Research Site
-
Reutlingen, Tyskland
- Research Site
-
Rostock, Tyskland
- Research Site
-
Tuebingen, Tyskland
- Research Site
-
Waltshut-Tiengen, Tyskland
- Research Site
-
Wuppertal, Tyskland
- Research Site
-
-
-
-
-
Budapest, Ungern
- Research Site
-
Debrecen, Ungern
- Research Site
-
Gyor, Ungern
- Research Site
-
Miskolc, Ungern
- Research Site
-
Nyiregyhaza, Ungern
- Research Site
-
Szeged, Ungern
- Research Site
-
Szekesfehervar, Ungern
- Research Site
-
-
-
-
-
Graz, Österrike
- Research Site
-
Innsbruck, Österrike
- Research Site
-
Wels, Österrike
- Research Site
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Manlig
Beskrivning
Inclusion Criteria:
Patients who answer TRUE to the following criteria may be eligible to participate in this study.
- Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
- Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
- Currently receiving treatment with surgical or medical castration
Exclusion Criteria:
Patients who answer TRUE to the following may NOT be eligible to participate in this study.
- Currently using opiate based pain killers for cancer related pain
- Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
- Suffering from heart failure or had a myocardial infarction within last 6 months
- A history of epilepsy or seizures
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Placebo
Matchande placebo
|
Matching Plcebo oral tablet once daily
|
|
Experimentell: ZD4054
ZD4054 (Zibotentan)
|
10 mg once daily oral dose
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Overall Survival
Tidsram: From date of randomization until date of death, assessed up to 33 months
|
Number of participants who have died at early analysis data cut off (DCO)
|
From date of randomization until date of death, assessed up to 33 months
|
|
Progression Free Survival
Tidsram: Participants were followed up for progression every 4 weeks for the first 16 weeks then every 16 weeks
|
Number of participants who have a progression event at the early analysis DCO, where progression is defined, using RECIST, as a measurable increase in the smallest dimension of any target or non-target lesion, or the appearance of new lesions, since baseline
|
Participants were followed up for progression every 4 weeks for the first 16 weeks then every 16 weeks
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Health Related Quality of Life
Tidsram: Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
|
Time to Prostate-specific Antigen (PSA) Progression
Tidsram: Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
|
Time to Symptomatic Progression
Tidsram: Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Kurt Miller, Prof., M.D., Charite University, Berlin, Germany
- Huvudutredare: Tia Higano, MD, University of Washington
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 januari 2008
Primärt slutförande (Faktisk)
1 januari 2011
Avslutad studie (Faktisk)
1 maj 2011
Studieregistreringsdatum
Först inskickad
24 januari 2008
Först inskickad som uppfyllde QC-kriterierna
21 februari 2008
Första postat (Uppskatta)
29 februari 2008
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
3 september 2012
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
29 augusti 2012
Senast verifierad
1 april 2012
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- D4320C00015
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .